Evidence map›Paper›PMID 41017086›Full record

ArticleCurrent drug discovery technologies2026

Analyze the Sombor Index of Molecular Graphs Representing Antibiotic Drugs using the ℳ Polynomial.

Jaishankar Senbagamalar, Mangalam Sivalingam Ramani, Venkata Shivakumar Remella

Abstract read
PubMed Publisher
In one paragraph

Article in Current drug discovery technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jaishankar SenbagamalarDepartment of Mathematics, Vel Tech Rangarajan Dr. Sagunthala R & D Institute of Science and Technology, Chennai, India.
Mangalam Sivalingam RamaniDepartment of Mathematics, M.O.P. Vaishnav College for Women, Chennai, India.
Venkata Shivakumar RemellaDepartment of Chemistry, Vel Tech Rangarajan Dr. Sagunthala R & D Institute of Science and Technology, Chennai, India.ORCID 0009-0005-7836-6525

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionToday's world is grappling with numerous infectious diseases and pandemics caused by bacteria, viruses, fungi, or parasites, which are affecting people at an alarming rate. Molecular topology, a field that significantly influences drug design and discovery, involves the algebraic description of chemical compounds, enabling their distinctive and straightforward characterization. MATERIALS AND

methodsAmong various applications, the topological indices can be generated from M-polynomial. ℳ-polynomial is a generating function that has been proposed to unify the computation of diverse topological indices. It contains degree-based topological data of molecular graphs and facilitates the derivation of multiple degree-based topological indices in an efficient manner. The ℳ- polynomial can be used to derive different degree-based topological indices by using different transformations. Computational efficiency offers a common method for calculating several topological indices. QSAR/QSPR Models are employed to examine molecular properties and biological activity in drug design.

resultsThe Sombor index, a molecular descriptor, was studied in the context of several antibacterial medications, including Amoxicillin, Ampicillin, Tetracycline, Doxycycline, Cefalexin, and Ciprofloxacin. These drugs are commonly used to treat conditions such as bladder infections, rickettsial infections, pneumonia, bronchitis, and other respiratory tract infections. DISCUSSION: In this study, the edge partition technique is employed to derive the ℳ-polynomial for selected antibacterial drug molecules. The graphical representation of the respective molecular structures is calculated and discussed based on the derived ℳ-polynomial.

conclusionTo construct the ℳ-polynomial and derive the Sombor index for antibiotic drugs, then correlate them with the physicochemical properties of these drugs to analyze the regression models for the best fit.

Indexed as

Anti-Bacterial AgentsDrug DesignQuantitative Structure-Activity RelationshipAnti-Bacterial AgentsAntibiotic drugsmolecular structurepolynomialsrespiratory tract infectionsSombor indextopological indices

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.